SEATTLE, WA – MAY 10: Erin Yang holds tubes of proteins while working on vaccine and protein research in the King Lab at the University of Washington on May 10, 2022 in Seattle, Washington. A new COVID-19 vaccine, GPB510, has been developed at the University of Washington School of Medicine by the King Lab and the Veesler Lab. (Photo by David Ryder/Getty Images)SEATTLE, WA – MAY 10: Erin Yang holds tubes of proteins while working on vaccine and protein research in the King Lab at the University of Washington on May 10, 2022 in Seattle, Washington. A new COVID-19 vaccine, GPB510, has been developed at the University of Washington School of Medicine by the King Lab and the Veesler Lab. (Photo by David Ryder/Getty Images)SEATTLE, WA – MAY 10: Erin Yang holds tubes of proteins while working on vaccine and protein research in the King Lab at the University of Washington on May 10, 2022 in Seattle, Washington. A new COVID-19 vaccine, GPB510, has been developed at the University of Washington School of Medicine by the King Lab and the Veesler Lab. (Photo by David Ryder/Getty Images)SEATTLE, WA – MAY 10: Erin Yang holds tubes of proteins while working on vaccine and protein research in the King Lab at the University of Washington on May 10, 2022 in Seattle, Washington. A new COVID-19 vaccine, GPB510, has been developed at the University of Washington School of Medicine by the King Lab and the Veesler Lab. (Photo by David Ryder/Getty Images)
